An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer

被引:19
|
作者
Zhao, Nan [1 ]
Yang, Ruijie [1 ]
Wang, Junjie [1 ]
Zhang, Xile [1 ]
Li, Jinna [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
MODULATED RADIATION-THERAPY; ARC THERAPY; HELICAL TOMOTHERAPY; PLAN QUALITY; IMRT; VMAT; RADIOTHERAPY; OPTIMIZATION; VOLUME; EFFICIENCY;
D O I
10.1155/2015/613060
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The study is to investigate a Hybrid IMRT/VMAT technique which combines intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nonsmall cell lung cancer (NSCLC). Two partial arcs VMAT, 5-field IMRT, and hybrid plans were created for 15 patients with NSCLC. The hybrid plans were combination of 2 partial arcs VMAT and 5-field IMRT. The dose distribution of planning target volume (PTV) and organs at risk (OARs) for hybrid technique was compared with IMRT and VMAT. The monitor units (MUs) and treatment delivery time were also evaluated. Hybrid technique significantly improved the target conformity and homogeneity compared with IMRT and VMAT. The mean delivery time of IMRT, VMAT, and hybrid plans was 280 s, 114 s, and 327 s, respectively. The mean MUs needed for IMRT, VMAT, and hybrid plans were 933, 512, and 737, respectively. Hybrid technique reduced V-5, V-10, V-30, and MLD of normal lung compared with VMAT and spared the OARs better with fewer MUs with the cost of a little higher V-5, V-10, and mean lung dose (MLD) of normal lung compared with IMRT. Hybrid IMRT/VMAT can be a viable radiotherapy technique with better plan quality.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Biological therapies in nonsmall cell lung cancer
    Zugazagoitia, Jon
    Molina-Pinelo, Sonia
    Lopez-Rios, Fernando
    Paz-Ares, Luis
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [22] Modern therapies of nonsmall cell lung cancer
    Jachowski, Andrzej
    Marcinkowski, Mikolaj
    Szydlowski, Jakub
    Grabarczyk, Oskar
    Nogaj, Zuzanna
    Marcin, Laz
    Plawski, Andrzej
    Jagodzinski, Pawel Piotr
    Slowikowski, Bartosz Kazimierz
    JOURNAL OF APPLIED GENETICS, 2023, 64 (04) : 695 - 711
  • [23] CHEMOTHERAPY OF NONSMALL CELL LUNG-CANCER
    MCVIE, JG
    ANNALS OF ONCOLOGY, 1993, 4 (10) : 804 - 805
  • [24] Immunotherapy for nonsmall-cell lung cancer
    Belalcazar, Astrid
    Raez, Luis E.
    Santos, Edgardo S.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (02) : 90 - 93
  • [25] Neoadjuvant immunotherapy in nonsmall cell lung cancer
    Pall, Georg
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 59 - 63
  • [26] Individualizing treatment of nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (01) : 35 - 36
  • [27] Immunotherapy for nonsmall-cell lung cancer
    Astrid Belalcazar
    Luis E. Raez
    Edgardo S. Santos
    memo - Magazine of European Medical Oncology, 2012, 5 (2) : 90 - 93
  • [28] GEMCITABINE IN NONSMALL CELL LUNG-CANCER
    SORENSEN, JB
    LUNG CANCER, 1995, 12 : S173 - S175
  • [29] Dosimetric comparison between IMRT and VMAT in irradiation for peripheral and central lung cancer
    Li, Yi
    Wang, Ji
    Tan, Li
    Hui, Beina
    Ma, Xiaowei
    Yan, Yanli
    Xue, Chaofan
    Shi, Xiaoting
    Drokow, Emmanuel Kwateng
    Ren, Juan
    ONCOLOGY LETTERS, 2018, 15 (03) : 3735 - 3745
  • [30] Personalised medicine for nonsmall cell lung cancer
    Mascaux, Celine
    Tomasini, Pascale
    Greillier, Laurent
    Barlesi, Fabrice
    EUROPEAN RESPIRATORY REVIEW, 2017, 26 (146):